Detecting 72 genes most commonly mutated in lung cancer

Detecting 72 genes most commonly mutated in lung cancer

Anatomy - Pathology / Cytogenetics / Molecular Diagnostics

December 14, 2016

Interested in the simultaneous detection of 72 genes most commonly mutated in lung cancer with high confidence? The newly developed Human Lung Cancer QIAseq DNA Panel provides you with a complete Sample to Insight solution and a simple, streamlined workflow.

The panel combines single primer extension (SPE) technology and unique molecular indices (UMIs) to enable sequencing of GC-rich regions, direct quantitation of CNVs, accurate expression level measurement and variant call validation. The simplicity of the system makes it ideal for routine known and novel lung cancer mutation detection on any NGS platform from Illumina and Ion Torrent.

Innovative NGS technology for gene expression profiling

Innovative NGS technology for gene expression profiling

Anatomy - Pathology / Cytogenetics / Molecular Dia...

We’ve got 6 reasons for you to move beyond qPCR for gene expression profiling! QIAGEN’s QIAseq Targeted RNA Panels offer you a simple and complete Sample to Insight solution for pathway- or disease-focused gene expression profiling with unmatched accuracy, sensitivity, specificity, reproducibility and high throughput.

January 09, 2017 More +
Blood-based biomarkers for COVID-19

Blood-based biomarkers for COVID-19

Anatomy - Pathology / Cytogenetics / Molecular Dia...

Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.

June 23, 2020 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us